---

$0.67

-0.0250 ( -3.60% ) 35.5K

Reviva Pharmaceuticals Holdings Inc is a late-stage pharmaceutical company that discovers, develops, and seeks to commercialize therapeutics for diseases. The current pipeline of the company focuses on the central nervous system, inflammatory, and cardiometabolic diseases. The company uses a chemical genomics-driven technology platform and proprietary chemistry to develop new medicines. The company's pipeline currently has two drug candidates, Brilaroxazine (RP5063) which is intended to treat multiple neuropsychiatric indications, including schizophrenia, bipolar disorder, depressive disorder, attention-deficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia or Alzheimer's disease, and Parkinson's disease psychosis and its other drug candidate is RP1208.

Type: All Buy Sale Start date: End date: Filter Reset

Date	Type	Amount Purchased	Purchaser
2023-11-22	Sale	-585366.00	SAXENA PARAG
2023-11-14	Sale	-8200.00	SAXENA PARAG
2023-11-14	Sale	-8200.00	Patel Purav
2023-11-14	Sale	-8200.00	Margolin Richard A
2023-11-14	Sale	-8200.00	Funtleyder Leslie D.